Organto Foods (OGO) Q2 2025 earnings summary

Executive summary

• Achieved record quarterly sales of $17.2 million in Q2 2025, up 291% year-over-year, and six-month sales of $30.8 million, up 241% year-over-year.

• Gross profit reached $1.3 million in Q2 (up 352%) and $2.4 million for six months (up 325%), both historic highs.

• Cash operating expenses as a percentage of sales improved significantly, reflecting operational leverage.

• Net losses for Q2 and six months were $7.4 million and $7.6 million, respectively, impacted by non-recurring debt restructuring and settlement costs.

Financial highlights

• Q2 sales: $17.2 million vs. $4.4 million prior year; six-month sales: $30.8 million vs. $9.0 million prior year.

• Q2 gross profit: $1.3 million (7.4% margin); six-month gross profit: $2.4 million (7.7% margin).

• Adjusted gross profit for Q2: $0.7 million (4.1% margin); for six months: $1.8 million (6.0% margin), reflecting currency hedging impacts.

• EBITDA for Q2: $(0.5) million; for six months: $(0.2) million, both improved from prior year.

Outlook and guidance

• Management expects continued growth and stability, citing restructuring and business realignment as foundations for future profitability.

• Proceeds from ongoing private placement will support product growth, technology development, and working capital.